India IP Litigation
7,302 annotated decisions
Page 10 of 305 · 7,302 total
Sun Pharmaceutical Industries Limited v.Meghmani Lifesciences Limited
Sun Pharmaceutical Industries Limited filed a commercial suit against Meghmani Lifesciences Limited for infringement of its registered trademark 'RACIRAFT'. The court found that the defendant's mark 'ESIRAFT' was deceptively similar to the plaintiff's mark and granted an injunction. The court applied the test of phonetic similarity and first impression to determine the likelihood of confusion. The decision highlights the importance of protecting intellectual property rights in the pharmaceutical industry.
Unique Enterprenuers And Finance Limited v.Really Agritech Private Limited
The appeal challenged a judgment that revoked an interim injunction and dismissed the plaintiff's urgent relief application. The core dispute involved alleged infringement and passing off between the appellant (using 'RALLI') and the respondent (using 'Really'). The court found that the appellant was aware of the defendant's use of the mark since 2018, based on participation in a fair and subsequent WhatsApp exchanges.
Unique Enterprenuers And Finance Limited v.Really Agritech Private Limited
The appeal challenged a single judge's order that vacated an interim injunction and revoked leave granted under Section 12A of the Commercial Courts Act, 2015. The appellant claimed infringement and passing off based on the defendant using 'Really' while the appellant used 'RALLI'. The court found evidence (participation in a 2018 fair and subsequent WhatsApp exchanges) establishing that the appellant was aware of the respondent's product use since at least 2018, dismissing the appeal.
Laser Shaving India Private Limited v.Rkrm International Products Private Limited
The Bombay High Court dismissed the Commercial Appeal filed by Laser Shaving India Private Limited against Rkrm International Products Private Limited, upholding the lower court's order refusing a temporary injunction. The court found that the plaintiff had suppressed relevant material and was estopped from seeking relief due to its previous stand before the Registrar of Trade Marks. The defendant had commenced selling impugned products after the plaintiff's representation to Galactic, and the court concluded that the elements of estoppel were satisfied.
Ever Resource Ltd & Anr. v.The Controller General of Patents Designs and Trademarks
This is an appeal filed by Ever Resource Ltd & Anr. challenging an order dated 31.12.2025 passed by The Controller General of Patents Designs and Trademarks under Section 15 of the Patents Act, 1970. The court also addressed several interlocutory applications regarding additional documents, exemptions, and condonation of delay.
Brown-Forman Distillery, Inc v.Brewholik Private Limited And Anr
The Delhi High Court dismissed an application by Brewholik Private Limited to sell existing stock of whiskey bearing the trademark 'OLD FORESTER', which is registered by Brown-Forman Distillery, Inc. The court held that the sale of the seized goods would be violative of the provisions of the Excise Act, 2009 and the Act. The court also noted that the plaintiff had vehemently disputed the quality of the seized goods, alleging them to be counterfeit.
Mechmaark Filtechindia Private Limited v.Asawa Insulation Private Limited & Anr.
The petitioner filed a petition seeking the revocation of Indian Patent no. 532136, which was granted to respondent no. 1 (Asawa Insulation Pvt. Ltd.). The court issued notices and set timelines for filing replies and rejoinders.
AFR M/s Ele Animations (P) Ltd. v.Satya Swagat Mohanty
The petitioner challenged an order rejecting its application to reject a plaint filed by the respondent. The suit involved allegations of copyright infringement concerning artistic works depicting 'Lord Jagannath' and 'Jagan.' The core legal issue was whether the case qualified for exemption from mandatory pre-institution mediation under Section 12-A of the Commercial Courts Act, 2015, based on the claim of urgent interim relief.
Asustek Computer Inc v.Nokia Technologies Oy
The petitioners, Asustek Computer Inc, filed petitions seeking the revocation and removal of two specific Indian Patents (Nos. 381056 and 320467) from the patent register. The court also addressed several interlocutory applications concerning exemptions and procedural matters.
Asustek Computer Inc v.Nokia Technologies Oy
The Delhi High Court heard petitions filed by Asustek Computer Inc seeking the revocation and removal of two specific Indian Patents (Nos. 381056 and 320467) from the register. The court also addressed several interlocutory applications regarding document division and exemptions.
Jntl Consumer Health I (Switzerland) Gmbh v.The Controller Of Patents
The appellant filed an application seeking condonation of a seven-day delay in filing an appeal. The court allowed this application. Subsequently, the main appeal was listed to challenge the Controller's decision refusing the appellant's patent application.
Communication Components Antena Inc v.Rosenberger Hochfrequenztechnik Gmbh & Co. KG
The plaintiff, Communication Components Antena Inc., filed a suit seeking a permanent injunction against infringement of Indian Patent No. 240893 concerning 'Asymmetrical Beams For Spectrum Efficiency'. The dispute involved multiple entities within the Rosenberger Group accused of manufacturing and selling infringing antennas.
President And Fellows Of Harvard College v.Controller General Of Patents Designs and Trademarks
The Appellant appealed against the Controller General's refusal to grant a patent application concerning SC-β cells. The rejection was based on objections regarding definitiveness, non-patentability, and sufficiency of disclosure. The High Court set aside the impugned order and remanded the matter for fresh consideration by another officer due to significant changes in the claims.
Alkem Laboratories Limited v.Novartis Ag & Anr.
Alkem Laboratories Limited filed a petition seeking the revocation of Indian Patent IN414518 and its removal from the Register of Patents. The respondent submitted that the patent in question had already been revoked, which was acknowledged by the petitioner's counsel.
Nec Corporation v.Assistant Controller Of Patents And Designs
Nec Corporation appealed the Assistant Controller's refusal of its patent application concerning a video coding device and method. The refusal was based on the lack of inventive step in light of existing prior art disclosures. The High Court ultimately dismissed the appeal, finding that the invention was rendered obvious by D1 to D3.
Scipharm Sarl v.Assistant Controller Of Patents And Designs and Anr
Scipharm Sarl appealed the rejection of its patent application for a method enhancing engraftment of haematopoietic stem cells. The High Court allowed the appeal, permitting the appellant to amend the claims by deleting claim no.1 and retaining claims 2 to 5, and remanded the matter back to the Controller's office for further consideration.
Bardana Super Hi-Tech Agro Tonic Pvt v.Amcons Ipl (Agro Industrial Expansion) Pvt Ltd and Others
The plaintiff filed a commercial suit seeking permanent injunctions against the defendants for dishonestly adopting and using the impugned mark "SUPER AGRO-TECH" along with deceptively similar packaging and trade dress in relation to agricultural goods. The applicant sought dispensation of pre-institution mediation, arguing that urgent interim relief was necessary due to immediate market confusion and injury.
Chugai Seiyaku Kabushiki Kaisha & Anr. v.Basil Drugs And Pharmaceuticals Private Limited
The plaintiffs, Chugai Seiyaku Kabushiki Kaisha & Anr., filed a commercial suit alleging infringement of their patent (IN 294424) related to the compound Alectinib. The court addressed several interlocutory applications and subsequently registered the plaint as a suit, while also granting an interim injunction restraining the defendant from manufacturing or dealing in infringing products.
Gsp Crop Science Private Limited v.Fmc Agro Singapore Pte Ltd & Ors.
The court addressed arguments regarding the maintainability and survival of a revocation petition under Section 64 of the Patents Act, 1970. The order noted that a Division Bench had held that such a petition remains maintainable even after patent expiry or when an invalidity defence is raised in suit.
Msn Laboratories Pvt. Ltd v.The Controller Of Patents & Anr.
The petitioner sought orders regarding the maintainability and survival of a revocation petition under Section 64 of the Patents Act, 1970. The court noted that the issue had been addressed by a Division Bench judgment in another appeal (Boehringer Ingelheim Pharma GMBH vs. The Controller of Patents & Anr).
Novo Nordisk A/S & Anr v.Dr. Reddy's Laboratories Limited
Novo Nordisk filed a commercial suit seeking an interim injunction against Dr. Reddy's Laboratories concerning their patented composition involving semaglutide. The court heard arguments, noted affidavits from both sides, and allowed procedural applications while directing the parties to proceed with pleadings.
Novartis Ag v.Bdr Pharmaceuticals International Private Limited
This order addresses several interlocutory applications filed by Novartis Ag against Bdr Pharmaceuticals International. The court granted exemptions from pre-institution mediation and allowed additional documents, while also considering arguments regarding the scope of the defendants' license under the Patents Act.
Wirtgen Gmbh v.Controller General Of Patents, Designs and Trademarks and Ors
Wirtgen Gmbh appealed a rejection order issued by the Controller General of Patents, Designs and Trademarks. The rejection was based on lack of inventive step and insufficient claim definition under the Patents Act. The High Court found that the impugned order suffered from analytical and procedural deficiencies.
Daewoong Pharmaceutical Co. Ltd. v.Controller General Of Patents Designs and Trademarks
Daewoong Pharmaceutical appealed the rejection of its patent application (No. 201817048074) by the Controller General, which was based on non-patentability under Section 3(d). The appeal challenged the decision to reject the application despite submissions regarding improved therapeutic efficacy and stability data.